|
Issue |
Title |
|
Vol 2, No 2 (2016) |
Oligoadenylate synthetase 1 (OAS1) expression in human breast and prostate cancer cases, and its regulation by sex steroid hormones |
Abstract
PDF
|
Cláudio Jorge Maia, Sandra Moreira Rocha, Sílvia Socorro, Fernando Schmitt, Cecília Reis Santos |
|
Vol 2, No 2 (2016) |
Older people’s experience of radiotherapy services |
Abstract
PDF
|
Louise Hogan, Anita O'Donovan |
|
Vol 2, No 2 (2016) |
Are we sleeping on the job? Insomnia among men with prostate cancer |
Abstract
PDF
|
Frances Josephine Drummond |
|
Vol 3, No 6 (2017) |
Focal therapy: A treatment option for localised prostate cancer? |
Abstract
PDF
|
Aisling Glynn, Elizabeth Forde, Laure Marignol |
|
Vol 2, No 6 (2016) |
Improving non-invasive detection of prostate cancer using diffusion-weighted MRI |
Abstract
PDF
|
Michelle Leech, John Gaffney, Laure Marignol |
|
Vol 2, No 1 (2016) |
Lysophosphatidic acid receptor isoforms expression in prostate cancer cells is differentially regulated by the CYP17A1 inhibitor abiraterone and depends on the androgen receptor |
Abstract
PDF
|
Matthias S Stope, Robert Mandelkow, Daniela Brunnert, Martin Weiss, Martin Burchardt |
|
Vol 2, No 1 (2016) |
Personalized hormonal treatment for prostate cancer: An opportunity for improvement |
Abstract
PDF
|
Omar Abdel-Rahman |
|
1 - 7 of 7 Items |
|